Cyclosporin A Therapy in Childhood Nephrotic Syndrome

NCT03219684 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2017-07-17

No results posted yet for this study

Summary

Nephrotic syndrome (NS) is among the most common pediatric kidney diseases and is defined as massive proteinuria (\>40 mg/m2/h or urine protein to creatinine ratio \>2 g/g) leading to hypoalbuminemia (\<2.5 g/dL), edema, and hyperlipidemia. 60-70 % of patients present prior to age of 6 years

Conditions

  • Steroid Dependent and Steroid Resistent Nephrotic Syndrome

Interventions

DIAGNOSTIC_TEST

serum protein ,kidney function ,liver function.,serum cholesterol

monthly review of serum protein kidney function ,liver function and serum cholesterol in all patients

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
1 Year
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-01
Primary Completion
2019-04-01
Completion
2019-08-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03219684 on ClinicalTrials.gov